Freestone Grove Partners LP Exact Sciences Corp Transaction History
Freestone Grove Partners LP
- $13.4 Trillion
- Q3 2025
A detailed history of Freestone Grove Partners LP transactions in Exact Sciences Corp stock. As of the latest transaction made, Freestone Grove Partners LP holds 15,384 shares of EXAS stock, worth $1.03 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
15,384
Previous 214,411
92.82%
Holding current value
$1.03 Million
Previous $11.4 Billion
92.61%
% of portfolio
0.01%
Previous 0.09%
Shares
2 transactions
Others Institutions Holding EXAS
# of Institutions
673Shares Held
164MCall Options Held
2.21MPut Options Held
1.69M-
Vanguard Group Inc Valley Forge, PA17.8MShares$1.19 Billion0.02% of portfolio
-
Capital World Investors Los Angeles, CA16.1MShares$1.08 Billion0.13% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$809 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA5.33MShares$357 Million0.05% of portfolio
-
State Street Corp Boston, MA5.2MShares$348 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $11.9B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...